Pembrolizumab and Nab Paclitaxel in Patients With Metastatic Urothelial Carcinoma
Clinical trial NCT03464734 · COMPLETED
Trial details
- NCT number
- NCT03464734
- Sponsor
- Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-16
- Primary completion
- 2020-01-21
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.